Sign in
4

Changes in Ownership

Axsome Therapeutics, Inc. Filed Acc 0001104659-19-016423

Director bought 5,100 shares at $12.18 ($62,118)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Coleman Mark Director 2019-03-19 Purchase +5,100 $12.18 $62,118 5,100 I
Open-market purchases · 5,100 sh · avg $12.18 · $62,118
Loading xslF345X03/a4.xml…